Many studies demonstrated that CD44 could present multiple isoforms through variable mRNA splicing and CD44 isoforms play critical roles in tumor initiation and be considered as potential treatment target in CRC compared with CD44 [34, 35]. The gene discussed is CD44; the disease is neoplasm.